Seres Therapeutics Inc (MCRB) Business News Oct. 29, 2025, 11:00 UTC Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155 Full text
There are no comments here yet...